IDDI sponsors the 2nd Annual Dry AMD Therapeutic Development Summit
Publié le
IDDI is a proud sponsor of the 2nd Annual Dry AMD Therapeutic Development Summit! Schedule a meeting with our BD…
Publié le
IDDI is a proud sponsor of the 2nd Annual Dry AMD Therapeutic Development Summit! Schedule a meeting with our BD…
Publié le
IDDI and XClinical webinar on the importance and the benefits Clinical Systems Integration WHAT YOU WILL LEARN:
Publié le
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Publié le
IDDI Complimentary Webinar on Minimization LEARN ON: Minimization method including demonstration of some of the advantages of minimization over permuted…
Publié le
Ophthalmology CRO IDDI is a leading global ophthalmology CRO offering biostatistics and eClinical solutions for ophthalmology studies. We have run nearly 100 trials in…
Publié le
Phase II study conducted with a dose-escalation minimization A phase II ophthalmology study was conducted with a dose-escalation minimization to…
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…